Literature DB >> 1359494

The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells.

K Reiss1, P Porcu, C Sell, Z Pietrzkowski, R Baserga.   

Abstract

We have investigated the role of the insulin-like growth factor one (IGF1) receptor and its relationship to the proto-oncogene c-myb in the growth of two types of hemopoietic cells: mitogen-stimulated human peripheral blood mononuclear cells and a human promyelocytic cell line (HL-60). Using the antisense strategy and the reverse transcriptase polymerase chain reaction (RT-PCR), we show that expression of the IGF1 receptor is required for the entry into S phase of both stimulated lymphocytes and HL-60 cells. The inhibition of DNA synthesis by antisense oligomers to the IGF1 receptor RNA is accompanied by an inhibition of the expression of the mRNA for a DNA synthesis gene, proliferating cell nuclear antigen (PCNA), the co-factor of DNA polymerase delta. Inhibition of c-myb expression results in a decrease in IGF1 receptor mRNA levels; on the other hand, inhibition of IGF1 receptor expression has no effect on c-myb mRNA levels. A tentative temporal relationship between these three genes (c-myb, IGF1 receptor, PCNA) is proposed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1359494

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  IRS-4 mediates protein kinase B signaling during insulin stimulation without promoting antiapoptosis.

Authors:  T Uchida; M G Myers; M F White
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 2.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

3.  Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia.

Authors:  K L Mohnike; U Kluba; U Mittler; V Aumann; P Vorwerk; W F Blum
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

4.  Elevated cyclin E levels, inactive retinoblastoma protein, and suppression of the p27(KIP1) inhibitor characterize early development of promyeloid cells into macrophages.

Authors:  Q Liu; R W VanHoy; J H Zhou; R Dantzer; G G Freund; K W Kelley
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 5.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

6.  Functional platelet-derived growth factor-beta (PDGF-beta) receptor expressed on early B-lineage precursor cells.

Authors:  B Trink; G Wang; M Shahar; N Meydan; C M Roifman
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

7.  Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts.

Authors:  C Sell; G Dumenil; C Deveaud; M Miura; D Coppola; T DeAngelis; R Rubin; A Efstratiadis; R Baserga
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

8.  Expression of functional insulin-like growth factor-1 receptor on lymphoid cell subsets of rats.

Authors:  X Xu; C Mardell; C J Xian; H Zola; L C Read
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

9.  Polyomavirus large T antigen induces alterations in cytoplasmic signalling pathways involving Shc activation.

Authors:  V Gottifredi; G Pelicci; E Munarriz; R Maione; P G Pelicci; P Amati
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro.

Authors:  Andrea E Wahner Hendrickson; Paul Haluska; Paula A Schneider; David A Loegering; Kevin L Peterson; Ricardo Attar; B Douglas Smith; Charles Erlichman; Marco Gottardis; Judith E Karp; Joan M Carboni; Scott H Kaufmann
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.